Medicinova Inc. Stock
Price
Target price
-
-
-
-
-
?7.72
WKN: A0LF3U / Symbol: MNOV / Name: MediciNova Inc / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Medicinova Inc. Stock
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Medicinova Inc..
Based on the current price of 3.22 € the target price of 7 € shows a potential of 117.53% for Medicinova Inc. which would more than double the current price.
Pros and Cons of Medicinova Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicinova Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicinova Inc. | - | - | - | - | - | - | - |
| Evolus Inc | -1.010% | -0.980% | -29.123% | -67.419% | -25.872% | -53.563% | -28.343% |
| Madrigal Pharmaceuticals inc. | 1.420% | -1.827% | -19.416% | 29.159% | -18.074% | 54.697% | 341.418% |
| Heron Therapeutics Inc. | -1.610% | -2.732% | 8.796% | -28.658% | 5.476% | -55.416% | -92.260% |
Comments
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat